Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112448 · ClinicalTrials.gov registry record · NA
Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT02112448 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 78 participants.
The verdict
NCT02112448, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
The investigators hypothesize that intermittent bolus doses of morphine and midazolam can provide the same pain control after pediatric cardiothoracic surgery as bolus doses plus infusions while using smaller total doses of both medications. The investigators will randomize patients to receive either morphine/midazolam as needed intermittently or morphine/midazolam drips plus intermittent doses to be received as needed. Pain scores will be recorded and total medications given will be recorded.
Interventions
- DRUG Acetaminophen
- DRUG ketorolac
- DRUG continuous infusion
- DRUG as needed dosing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02112448
The ClinicalTrials.gov registry entry for NCT02112448 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Acetaminophen is the first listed.
NCT02112448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02112448 about?
NCT02112448 is a clinical study titled "Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery". The investigators hypothesize that intermittent bolus doses of morphine and midazolam can provide the same pain control after pediatric cardiothoracic surgery as bolus doses plus infusions while using smaller total doses of both medications. The investigators will randomize patients to receive eith...
What is the current status of trial NCT02112448?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2014-06. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02112448?
The interventions under investigation include: Acetaminophen (DRUG), ketorolac (DRUG), continuous infusion (DRUG), as needed dosing (DRUG).
Who is sponsoring clinical trial NCT02112448?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.